Health and Fitness Health and Fitness
Thu, November 11, 2010
[ Thu, Nov 11th 2010 ] - Market Wire
Forest Laboratories Enters Collaboration on Bystolic® and Savella® in Canada
[ Thu, Nov 11th 2010 ] - Market Wire
Health Net Sponsors Iraq and Afghanistan Veterans of America Week 2010
[ Thu, Nov 11th 2010 ] - Market Wire
Array BioPharma to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
[ Thu, Nov 11th 2010 ] - Market Wire
Know the Signs and Stages of Alzheimer's
[ Thu, Nov 11th 2010 ] - Market Wire
Aetna to Enhance Global Emergency Assistance Program for Expatriate Members
[ Thu, Nov 11th 2010 ] - Market Wire
Zacks Releases Four Powerful ''Buy'' Stocks: Osir .. , Bancolombia, JAKKS Pacific and ReneSola Limited
[ Thu, Nov 11th 2010 ] - Market Wire
Biogen Idec, Greatbatch, Macya?s, Jamba and Gentiva Health Services
[ Thu, Nov 11th 2010 ] - Market Wire
Covidien plc, Johnson & Johnson, Becton Dickinson, C.R. Bard and Atmel Corporation
[ Thu, Nov 11th 2010 ] - Market Wire
Alnylam Pharmaceuticals, Roche, Novartis, Cubist Pharmaceuticals and Biogen Idec
[ Thu, Nov 11th 2010 ] - Market Wire
Corgenix Reports First Quarter Fiscal 2011 Financial Results
[ Thu, Nov 11th 2010 ] - Market Wire
Micromet Announces Pricing of Public Offering of 9.9 Million Shares of Common Stock
[ Thu, Nov 11th 2010 ] - Market Wire
DUSA Pharmaceuticals to Present at the 4th Annual Maxim Group Growth Conference
[ Thu, Nov 11th 2010 ] - Market Wire
Roche Diagnostics Signs Memorandum of Understanding for a Strategic Partnership with CapitalBio
[ Thu, Nov 11th 2010 ] - Market Wire
Geron Announces Two Publications Demonstrating Th .. lomerase Inhibitor Drug Targets Cancer Stem Cells
[ Thu, Nov 11th 2010 ] - Market Wire
Ceregene Raises $11.5 Million in Series D Financing
[ Thu, Nov 11th 2010 ] - Market Wire
GTx Announces Corporate Presentation at the Lazard Capital Markets Annual Healthcare Conference
[ Thu, Nov 11th 2010 ] - Market Wire
Gallup and Healthways Release October 2010 U.S. Well-Being Report
[ Thu, Nov 11th 2010 ] - Market Wire
Health Management Associates, Inc. to Present at .. 0 Bank of America Merrill Lynch Credit Conference
Wed, November 10, 2010
[ Wed, Nov 10th 2010 ] - Market Wire
Alliance Oncology Appoints John J. Kresl, M.D., Ph.D., to Chief Medical Officer
[ Wed, Nov 10th 2010 ] - Market Wire
Incytea?s Selective Oral JAK1 and JAK2 Inhibitor .. Ia Results in Patients with Active Rheumatoid Art
[ Wed, Nov 10th 2010 ] - Market Wire
SuperGen Discontinues Clinical Development of SGI-1776
[ Wed, Nov 10th 2010 ] - Market Wire
NUVO RESEARCH U.S. AWARDED US$1.3 MILLION IN RESEARCH GRANTS
[ Wed, Nov 10th 2010 ] - Market Wire
Bioject Reports Third Quarter 2010 Financial Results
[ Wed, Nov 10th 2010 ] - Market Wire
CORRECTING and REPLACING Health Net Earns Strong Regional Quality Rankings
[ Wed, Nov 10th 2010 ] - Market Wire
Micromet Announces the Sale of Common Stock
[ Wed, Nov 10th 2010 ] - Market Wire
St. Jude Medical and AGA Medical Announce Early Termination of HSR Waiting Period
[ Wed, Nov 10th 2010 ] - Market Wire
Biogen Idec to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
[ Wed, Nov 10th 2010 ] - Market Wire
DexCom to Present at Upcoming Investor Conferences
[ Wed, Nov 10th 2010 ] - Market Wire
Covidien to Present at Lazard Healthcare Conference
[ Wed, Nov 10th 2010 ] - Market Wire
Alkermesa? Corporate Presentation to be Webcast a .. the Lazard Capital Markets Healthcare Conference

Alkermesa? Corporate Presentation to be Webcast at the Lazard Capital Markets Healthcare Conference


Published on 2010-11-10 13:10:54 - Market Wire
  Print publication without navigation


WALTHAM, Mass.--([ BUSINESS WIRE ])--Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Lazard Capital Markets 7th Annual Healthcare Conference on Wednesday, November 17, 2010, at 1:15 p.m. ET from the St. Regis Hotel in New York City. The presentation may be accessed under the investor relations tab at [ www.alkermes.com ]. The presentation will be archived for 14 days.

Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes developed, manufactures and commercializes VIVITROL® for alcohol and opioid dependence and manufactures RISPERDAL® CONSTA® for schizophrenia and bipolar I disorder. Alkermes' robust pipeline includes extended-release injectable and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Waltham, Massachusetts, Alkermes has a research facility in Massachusetts and a commercial manufacturing facility in Ohio.

Contributing Sources